The impact of delay in time to surgical treatment of Merkel cell carcinoma on overall survival and disease specific survival: a population-based analysis

The aim of our study is to determine whether delays between diagnosis and surgical treatment of Merkel Cell Carcinoma (MCC) are associated with changes in overall survival (OS) and disease-specific survival (DSS). Using the Surveillance, Epidemiology, and End Results Program (SEER) database, our data does not show that delays are associated with worse OS or DSS.

本研究旨在探究诊断与梅克尔细胞癌（Merkel Cell Carcinoma，简称MCC）手术治疗之间的时间延误是否与患者总体生存期（Overall Survival，简称OS）及疾病特异性生存期（Disease-specific Survival，简称DSS）的变化相关。通过运用监测、流行病学和结果（Surveillance, Epidemiology, and End Results Program，简称SEER）数据库，本研究数据并未显示延误与更差的OS或DSS存在关联。